Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP471510.RAVEqNGjNGG9GCeZQG89_wrQE9EtnvV318aGvB8n-ctzc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP471510.RAVEqNGjNGG9GCeZQG89_wrQE9EtnvV318aGvB8n-ctzc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP471510.RAVEqNGjNGG9GCeZQG89_wrQE9EtnvV318aGvB8n-ctzc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP471510.RAVEqNGjNGG9GCeZQG89_wrQE9EtnvV318aGvB8n-ctzc130_provenance.
- NP471510.RAVEqNGjNGG9GCeZQG89_wrQE9EtnvV318aGvB8n-ctzc130_assertion description "[None of the remaining 44 tumors, including clear cell carcinoma (n = 12), transitional cell carcinoma (n = 1), mixed epithelial carcinoma (n = 7), carcinoma not otherwise specified (n = 1), and 31 borderline tumors (mucinous, n = 17; endometrioid, n = 7; serous, n = 7), showed Her-2/neu gene amplification or protein overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP471510.RAVEqNGjNGG9GCeZQG89_wrQE9EtnvV318aGvB8n-ctzc130_provenance.
- NP471510.RAVEqNGjNGG9GCeZQG89_wrQE9EtnvV318aGvB8n-ctzc130_assertion evidence source_evidence_literature NP471510.RAVEqNGjNGG9GCeZQG89_wrQE9EtnvV318aGvB8n-ctzc130_provenance.
- NP471510.RAVEqNGjNGG9GCeZQG89_wrQE9EtnvV318aGvB8n-ctzc130_assertion SIO_000772 15581965 NP471510.RAVEqNGjNGG9GCeZQG89_wrQE9EtnvV318aGvB8n-ctzc130_provenance.
- NP471510.RAVEqNGjNGG9GCeZQG89_wrQE9EtnvV318aGvB8n-ctzc130_assertion wasDerivedFrom befree-2016 NP471510.RAVEqNGjNGG9GCeZQG89_wrQE9EtnvV318aGvB8n-ctzc130_provenance.
- NP471510.RAVEqNGjNGG9GCeZQG89_wrQE9EtnvV318aGvB8n-ctzc130_assertion wasGeneratedBy ECO_0000203 NP471510.RAVEqNGjNGG9GCeZQG89_wrQE9EtnvV318aGvB8n-ctzc130_provenance.
- befree-2016 importedOn "2016-02-19" NP471510.RAVEqNGjNGG9GCeZQG89_wrQE9EtnvV318aGvB8n-ctzc130_provenance.